BATS BZX Real-Time Price
As of 10:18am ET
| +0.045 / +1.92%|
The 3 analysts offering 12-month price forecasts for CTi Biopharma Corp have a median target of 4.50, with a high estimate of 6.50 and a low estimate of 3.00. The median estimate represents a +88.68% increase from the last price of 2.38.
The current consensus among 4 polled investment analysts is to Buy stock in CTi Biopharma Corp. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.